HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizandra Braganhol Selected Research

methionine sulfoxide

4/2020Characterization of macrophage phenotype, redox, and purinergic response upon chronic treatment with methionine and methionine sulfoxide in mice.
1/2020Methionine and methionine sulfoxide induces neurochemical and morphological changes in cultured astrocytes: Involvement of Na+, K+-ATPase activity, oxidative status, and cholinergic and purinergic signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elizandra Braganhol Research Topics

Disease

36Glioma (Gliomas)
01/2022 - 08/2003
34Neoplasms (Cancer)
01/2022 - 07/2006
18Glioblastoma (Glioblastoma Multiforme)
04/2022 - 08/2009
14Inflammation (Inflammations)
12/2021 - 08/2009
9Necrosis
08/2021 - 02/2009
4Mitochondrial Diseases (Mitochondrial Disease)
04/2018 - 02/2011
4Brain Neoplasms (Brain Tumor)
03/2017 - 08/2007
3Hemolysis
11/2020 - 06/2015
3Hypermethioninemia
04/2020 - 10/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 01/2019
2Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 03/2010
2Melanoma (Melanoma, Malignant)
01/2020 - 04/2018
2Papillary Thyroid Cancer
01/2019 - 06/2018
2Mania (Manias)
10/2016 - 02/2014
2Down Syndrome (Down's Syndrome)
08/2015 - 06/2014
2Carcinogenesis
09/2014 - 07/2006
2Urinary Bladder Neoplasms (Bladder Cancer)
09/2014 - 05/2010
2Thrombosis (Thrombus)
12/2013 - 03/2010
2Hyperhomocysteinemia
12/2013 - 03/2010
2Familial Polythelia
10/2009 - 02/2009
1Pneumonia (Pneumonitis)
12/2021
1Sepsis (Septicemia)
12/2021
1Hepatocellular Carcinoma (Hepatoma)
12/2021
1Wounds and Injuries (Trauma)
12/2020
1Neuroinflammatory Diseases
12/2020
1Memory Disorders (Memory Loss)
12/2020
1Vascular Diseases (Vascular Disease)
09/2020
1Myocardial Infarction
09/2020
1Body Weight (Weight, Body)
04/2020

Drug/Important Bio-Agent (IBA)

18Adenosine Triphosphate (ATP)IBA
01/2021 - 08/2003
13Adenosine (Adenocard)FDA LinkGeneric
09/2020 - 04/2006
11EnzymesIBA
01/2021 - 08/2003
11NanocapsulesIBA
11/2020 - 08/2009
95'-Nucleotidase (5' Nucleotidase)IBA
01/2019 - 08/2003
8Adenosine Monophosphate (AMP)IBA
01/2021 - 08/2003
8AntioxidantsIBA
12/2020 - 10/2009
8Adenosine Diphosphate (ADP)IBA
01/2020 - 08/2003
7NucleotidesIBA
12/2021 - 08/2003
7Proteins (Proteins, Gene)FDA Link
06/2020 - 12/2008
6Temozolomide (Temodar)FDA LinkGeneric
04/2022 - 02/2009
6Pharmaceutical PreparationsIBA
01/2022 - 02/2013
4Biological ProductsIBA
01/2022 - 02/2009
4ectoATPaseIBA
12/2021 - 08/2009
4LipidsIBA
12/2020 - 02/2013
4Propidium (Propidium Iodide)IBA
01/2020 - 02/2009
4Apyrase (ATP Diphosphatase)IBA
01/2020 - 08/2009
4adenylyl(3'-5')cytidine-3'-phosphateIBA
05/2019 - 09/2007
4Messenger RNA (mRNA)IBA
01/2019 - 12/2008
4CurcuminIBA
03/2015 - 06/2012
3Conditioned Culture MediaIBA
01/2022 - 05/2015
3LipopolysaccharidesIBA
12/2021 - 01/2015
3beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
01/2021 - 05/2019
3Rosmarinic AcidIBA
12/2020 - 01/2019
3adenosine monophosphataseIBA
04/2020 - 01/2017
3NitritesIBA
04/2020 - 09/2019
3Purinergic Receptors (Receptors, Purine)IBA
01/2020 - 01/2013
3CatalaseIBA
01/2018 - 12/2016
3Adenine NucleotidesIBA
08/2015 - 04/2006
2CD39 antigenIBA
12/2021 - 06/2018
2ChitosanIBA
12/2020 - 01/2020
2Neuroprotective AgentsIBA
12/2020 - 07/2018
2ArginaseIBA
06/2020 - 04/2020
2methionine sulfoxideIBA
04/2020 - 01/2020
2Methionine (L-Methionine)FDA Link
04/2020 - 01/2020
2Small Interfering RNA (siRNA)IBA
04/2020 - 11/2019
2diphenyldiselenideIBA
01/2020 - 09/2019
2Oxygen (Dioxygen)IBA
04/2018 - 01/2018
2Complex MixturesIBA
01/2018 - 02/2009
2Superoxide DismutaseIBA
01/2018 - 01/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017 - 10/2016
2KetamineFDA LinkGeneric
10/2016 - 02/2014
2Biomarkers (Surrogate Marker)IBA
08/2015 - 09/2014
2Ketoprofen (Orudis)FDA LinkGeneric
06/2015 - 12/2013
2CytokinesIBA
05/2015 - 01/2015
2Dihydrotachysterol (AT 10)IBA
10/2009 - 02/2009
2NucleotidasesIBA
09/2007 - 08/2003
2QuercetinIBA
09/2007 - 07/2006
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1BromidesIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
12/2021
1Irritants (Vesicants)IBA
08/2021
1AntigensIBA
01/2021
1Biopolymers (Biopolymer)IBA
12/2020
1Thiobarbituric Acid Reactive SubstancesIBA
12/2020
1SuspensionsIBA
11/2020
1Phosphates (Orthophosphate)IBA
09/2020
1Saline SolutionIBA
04/2020
1HydrogelsIBA
01/2020
1xanthan gum (xanthan)FDA LinkGeneric
01/2020
1Tannic AcidFDA Link
01/2020
1AntibodiesIBA
11/2019
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2019
1PolymersIBA
08/2019
1VimentinIBA
05/2019

Therapy/Procedure

12Therapeutics
04/2022 - 02/2011
5Drug Therapy (Chemotherapy)
01/2022 - 08/2007
2Immunotherapy
01/2021 - 11/2019
2Intravenous Administration
11/2020 - 06/2015
1Ligation
12/2021
1Intranasal Administration
12/2020